Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Interim Management Statement

26 Jan 2009 16:20

RNS Number : 2639M
Standard Life Euro Pri Eqty Tst PLC
26 January 2009
 



Standard Life European Private Equity Trust PLC

Interim management statement for the quarter ended 31 December 2008

Standard Life European Private Equity Trust PLC ("the Company") presents its interim management statement for the period from 1 October 2008 to 31 December 2008. This announcement constitutes the Company's first interim management statement for the year ending 30 September 2009 in accordance with rule 4.3 of the UK Listing Authority's Disclosure and Transparency Rules. This interim statement summarises information as at 31 December 2008 and any material developments up to 26 January 2009

Investment objective

To achieve long-term capital gains through holding a diversified portfolio of private equity funds investing predominantly in Europe.

Benchmark

The Company has no defined benchmark.

Performance

The Company's audited net asset value per ordinary share ("NAV") was 234.8p as at 30 September 2008 (diluted - 231.4p). The Company's NAV as at 31 December 2008 will be announced on or around 24 March 2009. The share price of the Company's ordinary shares was 66.0p as at 31 December 2008, compared to 161.0p as at 30 September 2008, a decline of 59.0% over the quarter. Such a percentage fall was similar to that experienced by most of the London listed private equity investment trusts over that quarterOver the same quarter the MSCI Europe Index (sterling adjusted) fell 4.8% and the FTSE All Share Index fell 11.0%.

Financial position 

Against a background of significant volatility and declines in financial markets generally and a lower level of activity in the European private equity market, the Company received distributions from its private equity fund interests of £14.2 million during the quarter ended 31 December 2008 (quarter ended 31 December 2007 - £21.2 million) and funded £20.4 million of draw downs (quarter ended 31 December 2007 - £43.0 million). 

The Company had aggregate outstanding commitments to its private equity fund interests of £425.9 million as at 31 December 2008 (30 September 2008 - £389.2 million). The Company's outstanding fund commitments as at 31 December 2008 were positively impacted over the quarter by some of the material transactions referred to below and were negatively impacted by foreign exchange movements. Over the quarter to 31 December 2008 sterling depreciated by 18.5% and 19.3% against the euro and the US dollar respectively; these foreign exchange movements are unrealised.

As at 31 December 2008 the Company had net indebtedness of £47.6 million (30 September 2008 - net indebtedness of £36.4 million). As intimated in the Chairman's Statement and the preliminary announcement for the financial year ended 30 September 2008 the Company entered into a new £100 million three year syndicated revolving credit facility, led by The Royal Bank of Scotland plc, in November 2008. 

Material events and transactions 

The Company announced on 14 January 2009 that it had agreed the disposal of two of its private equity fund interests, as part of the Company's strategy of managing the quality of its portfolio and the quantum of its outstanding commitments. The Company sold its fund interests in BC European VIII and Towerbrook Investors III to significant institutional investors in the private equity asset class for an aggregate £7.5 million, as compared to the 30 September 2008 valuations of these fund interests, adjusted for subsequent cashflows, of £11.0 million. These two fund interests had aggregate outstanding commitments at the date of disposal of £46.7 million, from which the Company has now been released.

The Company also decided to elect to cap its exposure to Permira IV as part of the recently announced restructuring of that fund. The Company made a £30.3 million commitment to Permira IV in 2006 and as at the date of the election the outstanding commitment was £19.4 million. As part of the restructuring the Company has been released from £16.0 million of this outstanding commitment.

Taking account of the above disposals and election, drawdowns to date and the 15.8% and 23.3% depreciation of sterling compared to the euro and the US dollar respectively from 1 October 2008, the Company's total outstanding commitments were £374.0 million as at 23 January 2009. As at 23 January 2009 the Company's net indebtedness was £48.9 million; this is before the receipt of £0.9 million of proceeds from the disposal of the fund interest in Towerbrook Investors III. 

The Company is in discussions regarding the selective disposal of a limited number of its other private equity fund interests. In so doing, the Board and the Manager are sensitive to the need to ensure that the Company has sufficient outstanding commitments to benefit from future investment opportunities.

During the period from 1 October 2008 to 26 January 2009 the Company made no new private equity fund commitments.  

On 26 January 2009 shareholders approved a final dividend for the year ended 30 September 2008 of 0.7p per ordinary share at the Company's annual general meeting. This final dividend will be paid on 30 January 2009.

For further information please contact:-

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under Section 842 of the Income and Corporation Taxes Act 1988. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc."

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLGDBIBDGGCL
Date   Source Headline
17th Jan 20207:00 amRNSDoc re. Annual Report
15th Jan 20207:00 amRNSMonth End Net Asset Value(s)
14th Jan 20204:18 pmRNSDirector/PDMR Shareholding
9th Jan 20207:00 amRNSAnnual Financial Report
6th Jan 202011:31 amRNSQuarterly Disclosure
13th Dec 20197:00 amRNSMonth End Net Asset Value(s)
12th Dec 20197:00 amRNSFourth Quarter Dividend Declaration
14th Nov 20197:00 amRNSMonth end Net Asset Value(s)
12th Nov 20194:22 pmRNSDirector/PDMR Shareholding
1st Nov 20192:45 pmRNSDirector/PDMR Shareholding
14th Oct 201911:00 amRNSMonth End Net Asset Value(s)
3rd Oct 201911:05 amRNSQuarterly Disclosure
27th Sep 20192:50 pmRNSEstimated Net Asset Value at 31 August 2019
27th Sep 20192:44 pmRNSQuarterly Trading Statement
12th Sep 20197:00 amRNSDeclaration of Third Quarter Dividend
29th Aug 20197:05 amRNSCompany Secretary Change
14th Aug 20192:24 pmRNSDirector/PDMR Shareholding
14th Aug 20197:00 amRNSEstimated Net Asset Value at 31 July 2019
5th Aug 201911:10 amRNSDirector Declaration
30th Jul 201910:53 amRNSDirector/PDMR Shareholding
12th Jul 20197:00 amRNSEstimated Net Asset Value at 30 June 2019
2nd Jul 20191:11 pmRNSQuarterly Disclosure
19th Jun 20197:06 amRNSEstimated Net Asset Value at 31 May 2019
19th Jun 20197:00 amRNSHalf-year Report
13th Jun 20197:00 amRNSDividend Declaration
29th May 201911:30 amRNSUpdate research from QuotedData
15th May 20197:00 amRNSEstimated Net Asset Value as at 30 April 2019
2nd May 201911:02 amRNSDirector/PDMR Shareholding
12th Apr 20197:00 amRNSEstimated Net Asset Value at 31 March 2019
2nd Apr 20193:55 pmRNSQuarterly Disclosure
1st Apr 201910:08 amRNSChange of Depositary
25th Mar 20197:00 amRNSEstimated net asset value as at 28 February 2019
25th Mar 20197:00 amRNSQuarterly Trading Statement
14th Mar 201911:31 amRNSEdison issues review on Standard Life Private
14th Mar 20197:00 amRNSDividend Declaration
14th Feb 20197:00 amRNSEstimated Net Asset Value at 31 January 2019
29th Jan 20194:27 pmRNSDirector/PDMR Shareholding
22nd Jan 20192:17 pmRNSResult of AGM
15th Jan 20197:00 amRNSEstimated Net Asset Value at 31 December 2018
3rd Jan 20192:17 pmRNSQuarterly Disclosure
31st Dec 201811:18 amRNSDividend Declaration
27th Dec 201811:03 amRNSDirector/PDMR Shareholding
18th Dec 201811:27 amRNS2018 Annual Report and AGM
14th Dec 20187:00 amRNSEstimated Net Asset Value at 30 November 2018
12th Dec 20187:00 amRNSAnnual Financial Report
7th Dec 20184:05 pmRNSDirectorate Change
14th Nov 20187:00 amRNSEstimated Net Asset Value at 31 October 2018
6th Nov 20183:27 pmRNSDirector/PDMR Shareholding
2nd Nov 201812:02 pmRNSDirector/PDMR Shareholding
12th Oct 20187:00 amRNSEstimated Net Asset Value at 30 September 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.